TGA / PMDA / NMPA · Asia-Pacific
chimeric — TGA / PMDA / NMPA regulatory status
chimeric regulatory status in the Asia-Pacific is tracked from public TGA / PMDA / NMPA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: NMPA clinical trials.
Status snapshot
- Status
- NMPA clinical trials
- Structured fields
- 4
Regional decision snapshot — NMPA: clinical trials.
Linked evidence on this spoke: 16 published clinical programs and 12 related patent records. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.
Regulatory timeline
| Regulator | Region | Status | Date | Source |
|---|---|---|---|---|
| NMPA | China | clinical trials | — | Evidence |
Linked clinical programs
Related patents
| Number | Title | Jurisdiction |
|---|---|---|
| 12428463 | Chimeric antigen receptors targeting abnormal glycobiology | US |
| 12421292 | Anti-DLL3 chimeric antigen receptors and uses thereof | US |
| 12415867 | Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof | US |
| 12410232 | Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor | US |
| 12404347 | Glucuronoxylomannan (GXM) receptor chimeric antigen receptors and use thereof | US |
| 12398194 | Cell lexpressing two chimeric antigen receptors (CARs) at the cell surface | US |
| 12370261 | Chimeric peptides for antisense delivery | US |
| 12371466 | Chimeric antigen receptor and methods of use thereof | US |
| 12365879 | Synthetic chimeric poxviruses | US |
| 12358988 | Proteolytically cleavable chimeric polypeptides and methods of use thereof | US |
| 12351614 | CLEC9A-based chimeric protein complexes | US |
| 12351638 | Chimeric antigen receptors targeting BCMA and methods of use thereof | US |
Related hubs
FAQ
What is the TGA / PMDA / NMPA approval status of chimeric?
chimeric currently shows NMPA clinical trials in our Asia-Pacific regulatory index. Confirm on the official TGA / PMDA / NMPA label or EPAR before clinical or commercial use.
Where does NovaPharmaNews get chimeric regulatory data?
Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.
How many clinical programs are linked to chimeric?
This spoke lists 16 published programs associated with chimeric in our pipeline index.